Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Biomarkers Suggest Dieting Alternatives for Longevity

By Biotechdaily staff writers
Posted on 13 Aug 2002
A study on aging has revealed that men with lower body temperatures, lower blood insulin levels, and higher blood levels of dehydroepiandrosterone sulfate (DHEAS) as they aged tended to live longer without reducing calories, and that monkeys with these characteristics lived longer if their caloric intake was severely restricted. More...
These findings were reported in the August 2, 2002, issue of Science.

Investigators from the US National Institute of Aging (Bethesda, MD, USA) compared more than 700 healthy men, aged 19 to 95, with 60 rhesus monkeys, aged five to 25. The men were divided into two groups, based on whether they were in the upper or lower halves of the population for each of the three biomarkers--body temperature, blood insulin levels, and blood levels of DHEAS. The monkeys also were divided into two groups. One group was allowed to feed freely, typically consuming between 500 to 1,000 calories daily. A second group was fed a diet composed of at least 30% fewer calories than consumed by the unrestricted monkeys.

Biomarker and mortality data were collected on the men over a 25-year period, and biomarker data were gathered on the monkeys for five years beginning in 1987. Deaths among the monkeys have been tracked for more than 15 years.

Analysis of age-adjusted data revealed that among the participating men, those who had lower body temperatures, lower blood insulin levels, and higher blood levels of DHEAS as they aged tended to live longer. The calorically restricted monkeys showed a similar trend, and had half the death rate of monkeys allowed to feed freely.

None of the men, who reported consuming an average of 2,300 calories daily, was on a calorically restricted diet. "The fact that these men apparently were not practicing caloric restriction is important because it means there may be other ways to achieve biological hallmarks without having to undergo drastic dietary changes,” said Dr. George Roth, senior guest scientist at NIA and lead author of the study. "Although we do not yet know what these pathways are, this finding suggests it may be possible to develop compounds that offer the benefits of caloric restriction without having to resort to it.”




Related Links:
NIH/National Institute on Aging

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Spinal Fluid Cell Count Control
Spinalscopics
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.